According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -HK$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -HK$0.77 Billion | -1.18% |
2023 | -HK$0.77 Billion | 14.68% |
2022 | -HK$0.68 Billion | -5.62% |
2021 | -HK$0.72 Billion | 87.18% |
2020 | -HK$0.38 Billion | 32.24% |
2019 | -HK$0.29 Billion | -9.25% |
2018 | -HK$0.32 Billion | -22.5% |
2017 | -HK$0.41 Billion | 27.6% |
2016 | -HK$0.32 Billion | -20.82% |
2015 | -HK$0.41 Billion | 9.34% |
2014 | -HK$0.37 Billion | 33.05% |
2013 | -HK$0.28 Billion |